UBS Group has initiated coverage on Akamai Technologies (NASDAQ:AKAM) with a "neutral" rating and a $110 price target, indicating an 11.56% upside. Other analysts have varied opinions, with Oppenheimer and HSBC upgrading their ratings to "outperform" and "buy," respectively, while the consensus rating remains a "Moderate Buy" with a target price of $117.21. Akamai's stock recently traded at $98.60, with a market cap of $14.81 billion and a P/E ratio of 29.17.